An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Researchers have stressed that bird flu still poses a minimal risk to the general public, though that may change as the virus ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Robert F. Kennedy Jr. spent 2 days this week insisting to senators that he's not anti-vaccine. He said that he instead ...

The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...